Abstract
Agarose is a prominent marine polysaccharide representing reversible thermogelling behavior, outstanding mechanical properties, high bioactivity, and switchable chemical reactivity for functionalization. As a result, agarose has received particular attention in the fabrication of advanced delivery systems as sophisticated carriers for therapeutic agents. The ever-growing use of agarose-based biomaterials for drug delivery systems resulted in rapid growth in the number of related publications, however still, a long way should be paved to achieve FDA approval for most of the proposed products. This review aims at a classification of agarose-based biomaterials and their derivatives applicable for controlled/targeted drug delivery purposes. Moreover, it attempts to deal with opportunities and challenges associated with the future developments ahead of agarose-based biomaterials in the realm of advanced drug delivery. Undoubtedly, this class of biomaterials needs further advancement, and a lot of critical questions have yet to be answered.
| Original language | English |
|---|---|
| Pages (from-to) | 523-543 |
| Number of pages | 21 |
| Journal | Journal of Controlled Release |
| Volume | 326 |
| DOIs | |
| State | Published - 10 Oct 2020 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2020
Keywords
- Agarose
- Biomaterials
- Controlled release
- Drug delivery
- Natural polymers
ASJC Scopus subject areas
- Pharmaceutical Science
Fingerprint
Dive into the research topics of 'Agarose-based biomaterials for advanced drug delivery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver